2006
DOI: 10.1111/j.1478-3231.2006.01380.x
|View full text |Cite
|
Sign up to set email alerts
|

Serum levels of cytokeratin‐18 (tissue polypeptide‐specific antigen) in liver diseases

Abstract: Serum TPS (cytokeratin-18) is elevated in patients with non-malignant liver diseases, particularly in those with prominent cytolysis. Further studies are needed to evaluate the use of TPS as a marker of liver disease.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
24
4

Year Published

2007
2007
2021
2021

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 31 publications
(33 citation statements)
references
References 21 publications
(41 reference statements)
5
24
4
Order By: Relevance
“…All markers were also tested for correlations against serum creatinine, bilirubin, transaminases, and C-reactive peptide (CRP) levels. High levels of TPS were associated to high levels of transaminases, which is well in line with previous reports [22]. No other correlations could be observed for the conventional or the stromal derived tumour markers.…”
Section: Correlation Between Circulating Tumour Markerssupporting
confidence: 92%
“…All markers were also tested for correlations against serum creatinine, bilirubin, transaminases, and C-reactive peptide (CRP) levels. High levels of TPS were associated to high levels of transaminases, which is well in line with previous reports [22]. No other correlations could be observed for the conventional or the stromal derived tumour markers.…”
Section: Correlation Between Circulating Tumour Markerssupporting
confidence: 92%
“…Similar findings have been reported for TPA, TPS, and CYFRA in nonsmall cell lung cancers (44). However, these markers have somewhat limited clinical utility because of their lack of organ specificity and elevated serum levels in some nonmalignant diseases; for example, high CYFRA levels accompany interstitial pulmonary fibrosis (45), and high TPS levels are found in the context of several liver disorders (46). Additional data are needed to establish the clinical utility of serum SEK measurements in malignant disorders and the relative potential interference from nonmalignant diseases.…”
Section: Seks As Serum Markers Of Tissue Injury Epithelial Cancers supporting
confidence: 63%
“…The most commonly used markers are tissue polypeptide antigen (TPA; a mixture of CK8, CK18, and CK19), tissue polypeptide-specific antigen (TPS; derived from CK18), cytokeratin fragment 21-1 (CYFRA 21-1; derived from CK19) (Leers, Kolgen et al 1999;Marceau, Schutte et al 2007). High TPS levels have been reported in several liver disorders (Gonzalez-Quintela, Mallo et al 2006). …”
Section: Ck As Serum Markers and Ck Variants In Liver Diseasesmentioning
confidence: 99%